Robert Hawthorn — Endo Lab

article 1991

Low dose danazol in the treatment of the premenstrual syndrome

·doi:10.1136/pgmj.67.787.450

Summary This double-blind, randomized, crossover study compared the efficacy and safety of danazol (100 mg twice daily) with matching placebo in the treatment of severe premenstrual syndrome. Nineteen patients were randomly allocated to rec…

article 1989

Treatment of the premenstrual syndrome: A double blind placebo controlled cross over study using danazol

·doi:10.3109/01443618909151073

SummaryA double blind placebo controlled cross over study was conducted to assess the response of women with severe premenstrual syndrome to treatment with danazol. Daily self assessment of clinical state was measured using the Moos menstru…

article 1985

31 Danazol in the management of the pre-menstrual syndrome. A double-blind cross-over trial

·doi:10.1016/0022-4731(85)90354-1

article 1985

70 The effect of Danazol on high density lipoprotein cholesterol and apoproteins

·doi:10.1016/0022-4731(85)90393-0

article 1985

Danol for Premenstrual Syndrome: A Preliminary Report of a Placebo-Controlled Double-Blind Study

·doi:10.1177/030006058501300210

Introduction Danol (danazoI) is a synthetic steroid which has been found to be effective in the treatment of a variety of gynaecological and endocrinological disorders including endometriosis (Young & Blackmore 1977), fibroadenosis (Mansel …